Tri Locum Partners as of March 31, 2021
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 30 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Walgreen Boots Alliance (WBA) | 26.4 | $107M | 1.9M | 54.90 | |
| Regeneron Pharmaceuticals (REGN) | 7.6 | $31M | 65k | 473.15 | |
| Medtronic SHS (MDT) | 7.0 | $28M | 240k | 118.13 | |
| Johnson & Johnson (JNJ) | 6.9 | $28M | 169k | 164.35 | |
| Horizon Therapeutics Pub L SHS | 6.7 | $27M | 293k | 92.04 | |
| Baxter International (BAX) | 6.6 | $27M | 314k | 84.34 | |
| Bristol Myers Squibb (BMY) | 6.1 | $25M | 391k | 63.13 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 4.5 | $18M | 110k | 164.37 | |
| Humana (HUM) | 3.7 | $15M | 36k | 419.24 | |
| Nuance Communications | 3.6 | $15M | 334k | 43.64 | |
| Eli Lilly & Co. (LLY) | 2.2 | $9.0M | 48k | 186.82 | |
| 9 Meters Biopharma | 1.9 | $7.8M | 6.6M | 1.17 | |
| Tg Therapeutics (TGTX) | 1.8 | $7.2M | 149k | 48.20 | |
| Protagonist Therapeutics (PTGX) | 1.7 | $6.7M | 257k | 25.90 | |
| Myovant Sciences | 1.6 | $6.6M | 321k | 20.58 | |
| Aerie Pharmaceuticals | 1.5 | $6.2M | 349k | 17.88 | |
| Trillium Therapeutics Com New | 1.5 | $6.2M | 579k | 10.74 | |
| Aclaris Therapeutics (ACRS) | 1.0 | $4.1M | 164k | 25.20 | |
| Celldex Therapeutics Com New (CLDX) | 1.0 | $4.1M | 197k | 20.60 | |
| Syndax Pharmaceuticals (SNDX) | 1.0 | $4.0M | 180k | 22.36 | |
| Infinity Pharmaceuticals (INFIQ) | 1.0 | $3.9M | 1.2M | 3.23 | |
| Casi Pharmaceuticalsinc Com Stk | 0.9 | $3.6M | 1.5M | 2.40 | |
| Black Diamond Therapeutics (BDTX) | 0.9 | $3.5M | 143k | 24.26 | |
| Lifesci Acquisition Ii Corp Com A | 0.8 | $3.0M | 300k | 10.14 | |
| Cyclacel Pharmaceuticals | 0.5 | $2.1M | 293k | 7.11 | |
| Bellus Health Com New | 0.4 | $1.5M | 380k | 3.84 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.4 | $1.4M | 160k | 9.04 | |
| Immatics SHS (IMTX) | 0.3 | $1.4M | 122k | 11.21 | |
| Evolus (EOLS) | 0.3 | $1.1M | 81k | 13.00 | |
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.2 | $939k | 140k | 6.73 |
